EU Grants hero photo

EU Grants

Medinice S.A. implements its projects with the support of European Funds under the Operational Program Intelligent Development, the Operational Program Innovative Economy and the European Funds for Mazovia. Here you will find information about the projects we are implementing under specific programs and actions – you will learn about their goals, planned effects, as well as the total budget and the amount of funding.

EU logos

POIR sub-action 1.1.1

  • Project title: “MiniMax – the first universal cooled electrode for cardiac arrhythmia ablation for 3D heart navigation and mapping without X-ray radiation”
  • Medinice S.A. is implementing the project “MiniMax – the first universal cooled electrode for cardiac arrhythmia ablation for 3D heart navigation and mapping without X-ray radiation” under Measure 1.1: “R&D projects of enterprises of the Smart Growth Operational Programme 2014-2020 co-financed by the European Regional Development Fund.”
  • The total value of the project is PLN 4,731,379.33, with public funding amounting to PLN 2,995,042.43. Project implementation period: 01/04/2018 – 31/09/2023.

POIR sub-action 1.1.1

  • Project title: EP Bioptom–Electrophysiological diagnostic electrode for endomyocardial biopsy - project co-financed by European Funds
  • EP Bioptom is an electrophysiological diagnostic electrode for endomyocardial biopsy of the heart muscle guided by 3D electroanatomic mapping. Biopsy is a study that allows for morphological, immunohistochemical, and structural studies in electron microscopy. The introduction of 3D electroanatomic mapping (3D-EAM) systems has made it possible to create three-dimensional potential maps that allow for the identification of areas of the heart with pathological electrical function.
  • 3D-EAM systems allow for the creation of 3D-EAM with a potential map reflecting the areas of the border zone, scar, and healthy heart muscle. Additionally, 3D mapping allows for the determination of the conduction system and the vicinity of the valves, which reduces the risk of performing a biopsy from the area of the conduction system/valve apparatus and the associated complications. The appropriate application of this technology allows, among other things, for the precise localization of the arrhythmia source, determination of the 3D geometry of the heart chamber, designation of anatomical areas of interest, and manipulation of the catheter and positioning without X-ray radiation. 3D-EAM systems facilitate mapping and increase the likelihood of procedural success, particularly in complex cardiac arrhythmias and in cases of atypical heart anatomies.
  • The aim of the project is to develop an innovative product on a global scale - a multifunctional electrophysiological diagnostic electrode for endocardial biopsy of the heart muscle guided by 3D electroanatomic mapping.
  • The project value: total expenses: PLN 5,374,650.00, eligible expenses: PLN 5,374,650.00, contribution of European Funds: PLN 3,918,575.00.
EU logos

POIR sub-action 2.3.4

  • Project title: Obtaining international patent protection for the invention Cryoapplicator for Minimally Invasive Cardiac Ablation with Active Thawing System
  • Medinice S.A. is implementing a project under Measure 2.3 “Innovation support services for enterprises,” Sub-measure 2.3.4 “Protection of industrial property,” Priority Axis II: “Support for the environment and potential of enterprises in conducting R&D&I activities” of the Smart Growth Operational Programme 2014–2020.
  • The aim of the project is to obtain industrial property protection in the form of a patent for the Invention in the territories of i) the Netherlands, ii) Germany, iii) France, iv) Switzerland, v) India, vi) Canada, vii) the US, viii) Israel, ix) China, x) Japan, xi) South Korea, and to prepare the commercialization process for the Invention.
  • The planned outcome of the project is to prepare and submit 1 application in the European procedure (validation in the territory of 4 European countries) and 7 patent applications in national procedures. A total of 8 patent applications.
  • The total budget of the project is PLN 680,752.00, of which PLN 283,750.00 is co-financed by the EU. Project implementation period: 01/12/2017 – 31/12/2023.

POIR sub-action 2.3.4

  • Project title: Obtaining international patent protection for the invention Cryoapplicator for Minimally Invasive Cardiac Ablation with Functional Tip
  • Medinice S.A. is implementing a project under Measure 2.3 “Innovation support services for enterprises,” Sub-measure 2.3.4 “Protection of industrial property,” Priority Axis II: “Support for the environment and potential of enterprises in conducting R&D&I activities” of the Smart Growth Operational Programme 2014–2020.
  • The aim of the project is to obtain industrial property protection in the form of a patent for the Invention in the territories of i) the Netherlands, ii) Germany, iii) France, iv) Switzerland, v) India, vi) Canada, vii) the US, viii) Israel, ix) China, x) Japan, xi) South Korea, and to prepare the commercialization process for the Invention.
  • The planned outcome of the project is to prepare and submit 1 application in the European procedure (validation in the territory of 4 European countries) and 7 patent applications in national procedures. A total of 8 patent applications.
  • The total budget of the project is PLN 680,752.00, of which PLN 283,750.00 is co-financed by the EU. Project implementation period: 01/12/2017 – 31/12/2023.

POIR sub-action 2.3.4

  • Project title: Obtaining international patent protection for the invention Cannula for minimally invasive tricuspid valve repair
  • Medinice S.A. is implementing a project under Action 2.3 "Pro-innovative services for enterprises" Sub-action 2.3.4 "Protection of industrial property" of the Priority Axis II: "Support for the environment and potential of enterprises to conduct R&D&I activities" of the Intelligent Development Operational Program 2014-2020.
  • The aim of the project is to obtain industrial property protection in the form of a patent for the invention in the territory of: i) the Netherlands, ii) Germany, iii) France, iv) Switzerland, v) India, vi) Canada, vii) the United States of America, viii) Israel, ix) China, x) Japan, xi) South Korea, and to prepare the commercialization process of the invention.
  • The planned effect of the project is to prepare and submit 1 application in the European procedure (validation in the territory of 4 European countries) and seven patent applications in national procedures. A total of eight patent applications.
  • The total budget of the project is PLN 680,752.00, of which PLN 283,750.00 is co-financed by the EU. Project implementation period: 01/12/2017 – 31/12/2023.

POIR sub-action 2.3.4

  • Project title: Obtaining international patent protection for the invention Cannula for minimally invasive cannulation of the inferior vena cava
  • Medinice S.A. is implementing the project under Measure 2.3 "Pro-innovative services for enterprises" Sub-measure 2.3.4 "Protection of industrial property" of Priority Axis II: "Support for the environment and potential of enterprises to conduct R&D&I activities" of the Operational Program Intelligent Development 2014-2020.
  • The aim of the project is to obtain industrial property protection in the form of a patent for the Invention in the territory of: i) the Netherlands, ii) Germany, iii) France, iv) Switzerland, v) India, vi) Canada, vii) the US, viii) Israel, ix) China, x) Japan, xi) South Korea, and to prepare the commercialization process of the Invention.
  • The planned effect of the project is to prepare and submit 1 application in the European procedure (validation in the territory of 4 European countries) and seven patent applications in national procedures. A total of eight patent applications.
  • The total budget of the project is PLN 680,852.00, and its funding from EU funds is PLN 283,800.00. Project implementation period: 01/12/2017 - 31/12/2023.

POIG sub-action 5.4.1

  • In 2014, we received funding from the European Union for two innovative projects under the Operational Program Innovative Economy 2007-2013 Sub-measure 5.4.1 - Management of Intellectual Property.

We Care About Your Privacy

Medinice S.A. uses cookies to improve and customize users experience on our website. By selecting 'Accept', you consent to the use of all cookies that gather and use information about your interactions with our site to provide personalized content and enhance your digital experience. Please read our Privacy Policy for more information.

Contact

Address

Hankiewicza 2

02-103 Warszawa

Poland

Follow us

NIP: 6631868308

REGON: 260637552

KRS: 0000443282

EU logos
EU logos